New Drug Could Be Breakthrough in Treatment of Hodgkin’s Lymphoma
Published at
Anand Soundarajan/iStock/Thinkstock(NEW YORK) — Researchers say a new drug may be a breakthrough in the treatment of Hodgkin’s Lymphoma.
According to the study, published in the New England Journal of Medicine, the drug Nivolumab could be an effective means of treating the cancer in patients whose disease does not respond to chemotherapy or stem cell transplants. The drug works by blocking a particular pathway that aids in the spread of lymphoma.
The study was small, only including 23 patients, but an overwhelming percentage of them saw positive response to the drug. Nearly 20 percent had a “complete response.”
The new treatment is targeted for patients at the end-stage of their cancer. The testing on Nivolumab is in the preliminary stages.
Follow @ABCNewsRadio
Copyright 2014 ABC News Radio